Product Information
FEBUXOSTAT 80 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3297 per EA under NDC 33342027507. Its NADAC has been published 113 times since May 1, 2024.
Strength
80 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342027507
Classification
Generic
Dosage Form
FILM
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA207293On Market Since
4/4/2019
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 80 MG TABLET has been published 113 times since May 1, 2024, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3297 per EA |
|---|---|
| All-time high | $0.5895 (Nov 13, 2024) |
| All-time low | $0.2636 (Feb 18, 2026) |
| 52-week high | $0.4893 |
| 52-week low | $0.2636 |
| Median price | $0.4210 |
| Average price | $0.4168 |
| Largest weekly change | +30.2% (Aug 21, 2024) |
| Weeks tracked | 113 |
| Tracking since | May 1, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Febuxostat tablets 80 mg market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.3297 per EA (NDC 33342027507), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 12.9%. It has been tracked across 113 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?
Since May 1, 2024, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $0.5895 (Nov 13, 2024), with a median of $0.4210 per EA.
Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FEBUXOSTAT 80 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures FEBUXOSTAT 80 MG TABLET?
FEBUXOSTAT 80 MG TABLET (NDC 33342027507) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification